Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 20 Oct 22 EFFECT Notice of effectiveness
-
11 Oct 22 S-3 Shelf registration
EGRX similar filings
Filing view
External links
Exhibit 23.3
Consent of Independent Auditors
We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of Eagle Pharmaceutical, Inc., of our report dated August 25, 2022, relating to the financial statements of Acacia Pharma Group Limited and its subsidiaries, which appears in Eagle Pharmaceutical, Inc.’s Amendment No. 1 to the Current Report on Form 8-K dated August 25, 2022. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
London, United Kingdom
October 11, 2022